Editorial: Optimizing the first-line treatment for metastatic colorectal cancer

Front Oncol. 2024 Jan 24:14:1366383. doi: 10.3389/fonc.2024.1366383. eCollection 2024.
No abstract available

Keywords: CRC (colorectal cancer); QOL (quality of life); anti-EGFR; biomarkers; liver metastasis; panitumumab.

Publication types

  • Editorial

Grants and funding

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.